» Articles » PMID: 1693569

Estrogen Increases Galanin Immunoreactivity in Hyperplastic Prolactin-secreting Cells in Fisher 344 Rats

Overview
Journal Endocrinology
Specialty Endocrinology
Date 1990 Jun 1
PMID 1693569
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Galanin is a widely distributed regulatory peptide which modulates the pituitary secretion of PRL and GH. Estrogen administration strongly stimulates galanin gene expression in the rat anterior pituitary. In adult female Fischer 344 rats, estrogen also induces hyperplasia of lactotropes. We used immunocytochemical analysis to assess the effects of estrogen on galanin-like immunoreactivity (Gal-IR) in the rat pituitary and hypothalamus during sc diethylstilbestrol (DES) implantation and after its removal at 30 days. In the anterior pituitary, DES implantation increased the portion of Gal-IR-containing cells from less than 2% in the control rats to 18.3% after 3 days of DES and 36% after 30 days. These changes paralleled the lactotrope hyperplasia exhibited in response to DES exposure. Ten and 30 days after removal of the DES capsules, the percentage of Gal-IR-containing cells in the anterior pituitary decreased to 6.3% and 1.5%, respectively. Colocalization studies revealed that Gal-IR-containing cells were predominantly lactotropes. Immunoelectron microscopy demonstrated that Gal-IR was concentrated in the Golgi region of these hyperplastic lactotropes and suggests that little of the synthesized galanin is secreted. The distribution of Gal-IR in the hypothalamus, median eminence, and neurohypophysis was unaffected by DES treatment. These data demonstrate that galanin is synthesized by hyperplastic pituitary lactotropes of Fischer 344 rats and that peptide accumulation is dependent on the presence of circulating estrogens. In contrast, neuronal galanin synthesis in the hypothalamus does not appear to be regulated by estrogen.

Citing Articles

The Galaninergic System: A Target for Cancer Treatment.

Sanchez M, Covenas R Cancers (Basel). 2022; 14(15).

PMID: 35954419 PMC: 9367524. DOI: 10.3390/cancers14153755.


Corticotroph (Basophil) invasion of the pars nervosa in the human pituitary: Localization of proopiomelanocortin peptides, galanin and peptidylglycine α-amidating monooxygenase-like immunoreactivities.

Lloyd R, DAmato C, Thiny M, Jin L, Hicks S, Chandler W Endocr Pathol. 2020; 4(2):86-94.

PMID: 32138413 DOI: 10.1007/BF02914457.


Potential of gene therapy for the treatment of pituitary tumors.

Goya R, Sarkar D, Brown O, Herenu C Curr Gene Ther. 2004; 4(1):79-87.

PMID: 15032616 PMC: 2882190. DOI: 10.2174/1566523044578086.


Rat strain specific attenuation of estrogen action in the anterior pituitary gland by dietary energy restriction.

Harvell D, Buckles L, Gould K, Pennington K, McComb R, Shull J Endocrine. 2003; 21(2):175-83.

PMID: 12897383 DOI: 10.1385/ENDO:21:2:175.


Estrogen action in the regulation of cell proliferation, cell survival, and tumorigenesis in the rat anterior pituitary gland.

Spady T, McComb R, Shull J Endocrine. 2000; 11(3):217-33.

PMID: 10786818 DOI: 10.1385/ENDO:11:3:217.